MARTELL RON
Insider CIK 1177079 · SNTI Chief Executive Officer, Director · CTYX Director · KBIO Executive Chairman, Director · NGSX President and CEO, Director · JSPR President, CEO and Director, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 234,000 | — | $0 | 234,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy deriv | 2025-09-22 | 2025-09-24 | 41,000 | — | $0 | 41,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2025-09-22 | 2025-09-24 | 41,000 | $2.43 | $99.6K | 74,118 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 234,000 | — | $0 | 234,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 130,000 | — | $0 | 130,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-06-10 | 2024-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-06-10 | 2024-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | F Tax w/h | 2023-10-12 | 2023-10-13 | 87,531 | $0.85 | $74.4K | 331,188 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | F Tax w/h | 2023-04-12 | 2023-04-14 | 87,531 | $1.46 | $127.8K | 418,719 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-03-17 | 2023-03-20 | 500,000 | — | $0 | 500,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-02-02 | 2023-02-03 | 1,093,831 | — | $0 | 1,093,831 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award | 2022-10-12 | 2022-10-13 | 506,250 | — | $0 | 506,250 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 1,704,328 | — | $0 | 1,704,328 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | A Award deriv | 2017-01-26 | 2017-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-10-28 | 2015-10-28 | 3,125 | — | $0 | 3,125 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-09-28 | 2015-09-28 | 3,125 | — | $0 | 3,125 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-08-28 | 2015-09-22 | 3,125 | — | $0 | 3,125 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-07-30 | 2015-07-30 | 3,125 | — | $0 | 3,125 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-06-29 | 2015-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-05-28 | 2015-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-04-22 | 2015-04-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-04-22 | 2015-04-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SVON Sevion Therapeutics, Inc. | A Award deriv | 2014-11-18 | 2014-11-20 | 56,364 | — | $0 | 456,364 | SEC↗ |
| SNTI SENESCO TECHNOLOGIES INC | A Award deriv | 2014-06-25 | 2014-06-26 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NGSX NeurogesX Inc | M Exercise deriv | 2013-01-01 | 2013-01-03 | 25,000 | — | $0 | 75,000 | SEC↗ |
| NGSX NeurogesX Inc | M Exercise | 2013-01-01 | 2013-01-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-03-13 | 2012-03-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-03-13 | 2012-03-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-01-30 | 2012-02-01 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-01-30 | 2012-02-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-01-30 | 2012-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-01-30 | 2012-02-23 | 500,000 | — | $0 | 500,000 | SEC↗ |